Get started
Author

Inge L. Huibregtse

Observed names: I HUIBREGTSE, I Huibregtse, I L Huibregtse, I. Huibregtse, I. L. Huibregtse, I.L. (Inge) Huibregtse, I.L. Huibregtse, IL Huibregtse, Inge Huibregtse, Inge L Huibregtse, Inge Louise Huibregtse
Observed institutions: Tufts Medical Center, Catharina Ziekenhuis, Slotervaartziekenhuis, Amsterdam UMC Location University of Amsterdam, The Netherlands Cancer Institute, Maastricht University, University of Amsterdam, Delft University of Technology
OpenAlex ID: A5113669115
Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer
2024 · Myriam Chalabi, Yara L. Verschoor, et al. · New England Journal of Medicine · 551
PDF
Long-term Quality of Life and Functional Outcome of Patients With Rectal Cancer Following a Watch-and-Wait Approach
2023 · Petra A. Custers, Marit E. van der Sande, et al. · JAMA Surgery · 166
PDF
Induction of Ovalbumin-Specific Tolerance by Oral Administration of Lactococcus lactis Secreting Ovalbumin
2007 · Inge L. Huibregtse, Veerle Snoeck, et al. · Gastroenterology · 109
PDF
Neoadjuvant nivolumab, ipilimumab, and celecoxib in MMR-proficient and MMR-deficient colon cancers: Final clinical analysis of the NICHE study.
2022 · Yara L. Verschoor, José van den Berg, et al. · Journal of Clinical Oncology · 101
Induction of Antigen-Specific Tolerance by Oral Administration of Lactococcus lactis Delivered Immunodominant DQ8-Restricted Gliadin Peptide in Sensitized Nonobese Diabetic Ab° Dq8 Transgenic Mice
2009 · Inge L Huibregtse, Eric V Marietta, et al. · The Journal of Immunology · 90
Physical Interaction between GATA-5 and Hepatocyte Nuclear Factor-1α Results in Synergistic Activation of the Human Lactase-Phlorizin Hydrolase Promoter
2002 · Herbert M. van Wering, Inge L. Huibregtse, et al. · Journal of Biological Chemistry · 79
In Vitro and In Vivo Down-Regulation of Regulatory T Cell Activity with a Peptide Inhibitor of TGF-β1
2008 · Lucía Gil-Guerrero, Javier Dotor, et al. · The Journal of Immunology · 70
PDF
Immunopathogenesis of IBD: insufficient suppressor function in the gut?
2006 · I L Huibregtse, A U van Lent, et al. · Gut · 50
A prospective randomized trial of Tannenbaum-type Teflon-coated stents versus polyethylene stents for distal malignant biliary obstruction
2004 · Anne-Marie van Berkel, Inge L Huibregtse, et al. · European Journal of Gastroenterology & Hepatology · 36
Prevention of experimental colitis by parenteral administration of a pathogen-derived immunomodulatory molecule
2006 · Henri Braat, Peter McGuirk, et al. · Gut · 25
PDF
Genetically ModifiedLactococcus lactisfor Delivery of Human Interleukin-10 to Dendritic Cells
2011 · Inge L. Huibregtse, Sebatian A. Zaat, et al. · Gastroenterology Research and Practice · 24
PDF
Upper endoscopy after Roux-en-Y gastric bypass: diagnostic yield and factors associated with relevant findings
2020 · Thomas C.C. Boerlage, Paula J.D. Wolvers, et al. · Surgery for Obesity and Related Diseases · 20
Contact X-ray Brachytherapy for Older or Inoperable Rectal Cancer Patients: Short-Term Oncological and Functional Follow-Up
2021 · Petra A. Custers, Barbara M. Geubels, et al. · Cancers · 17
PDF
Fecal Calprotectin, Elastase, and Alpha-1-Antitrypsin Levels After Roux-en-Y Gastric Bypass; Calprotectin Is Significantly Elevated in the Majority of Patients
2016 · Thomas C. C. Boerlage, Floris Westerink, et al. · Obesity Surgery · 17
PDF
Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial
2023 · Maaike E Verweij, Max D Tanaka, et al. · BMJ Open · 15
247P Radiotherapy (RT), atezolizumab (atezo) and bevacizumab (bev) to increase organ preservation in rectal cancer: The TARZAN study
2024 · P.G.M. de Gooyer, Y.L. Verschoor, et al. · Annals of Oncology · 10
Faecal Inflammatory Biomarkers and Gastrointestinal Symptoms after Bariatric Surgery: A Longitudinal Study
2021 · Floris Westerink, Inge Huibregtse, et al. · Inflammatory Intestinal Diseases · 9
PDF
Plastic Biliary Stents for Malignant Biliary Diseases
2011 · Inge Huibregtse, Paul Fockens · Gastrointestinal Endoscopy Clinics of North America · 8
Outcomes of watch and wait after short-course radiotherapy in an international multicentre watch-and-wait cohort
2024 · Barbara M Geubels, Aart-Jan van den Esschert, et al. · British journal of surgery · 7
PDF
Lactose after Roux-en-Y gastric bypass for morbid obesity, is it a problem?
2020 · F. Westerink, H. Beijderwellen, et al. · Scandinavian Journal of Gastroenterology · 7
Setting up a regional expert panel for complex colorectal polyps
2022 · Liselotte W. Zwager, Barbara A.J. Bastiaansen, et al. · Gastrointestinal Endoscopy · 6
Features on Endoscopy and MRI after Treatment with Contact X-ray Brachytherapy for Rectal Cancer: Explorative Results
2022 · Petra A. Custers, Monique Maas, et al. · Cancers · 5
PDF
Development and provider assessment of a new oncology network with care pathways for gastrointestinal cancer patients: the collaborative approach
2025 · Britte H. E. A. ten Haaft, Eefje van Kessel, et al. · BMC Cancer · 2
PDF
Multicenter, Randomized Non-inferiority Trial Comparing Transanal Minimal Invasive Surgery (tamis) and Endoscopic Submucosal Dissection (esd) for Resection of Non- Pedunculated Rectal Lesions
2025 · Daan A. Verhoeven, Nik Dekkers, et al. · Gastrointestinal Endoscopy · 2
Multicenter, randomized non-inferiority trial comparing TRansanal minimal InvAsive Surgery (TAMIS) and endoscopic Submucosal dIsseCtion (ESD) for resection of non-pedunculated rectal lesions
2025 · D Verhoeven, N Dekkers, et al. · Endoscopy · 1
Works count: 43
Citation count: 1,429
H-index: 15
I10-index: 16
Year
Topic
Type